Table of Contents Table of Contents
Previous Page  1213 / 1416 Next Page
Information
Show Menu
Previous Page 1213 / 1416 Next Page
Page Background

Establishing Evidence-Based Indica3ons for Proton Therapy: An Overview of Current Clinical

Trials

Mark V. Mishra, Univ. Maryland, IJROBP, 2017 (97)

clinicaltrials.gov and the World Health Organiza3on Interna3onal Clinical Trials PlaSorm

Registry.

Total of 122 ac3ve PBT clinical trials iden3fied

Target enrollment of >42,000 pa3ents worldwide.

96 trials (79%), classified as interven3onal studies.

Observa3onal studies accounted for 21% of trials but 71% (n=29,852) of planned pa3ent

enrollment.

Most common: Gastrointes3nal tract tumors (21%, n=26), tumors of the central nervous

system (15%, n=18), and prostate cancer (12%, n=15).

5 ac3ve studies (lung, esophagus, head and neck, prostate, breast) will randomize pa3ents

between protons and photons, and 3 will randomize pa3ents between protons and carbon ion

therapy.